Grey Wolf Therapeutics
Series BOxford, UKJan 2023
Grey Wolf Therapeutics raised €45M in a Series B round in Jan 2023. The company is based in Oxford, UK. Investors in the round: Andera Partners, British Patient Capital, Canaan Partners and 3 others. Data as of Nov 2026.
Amount raised
€45M
€44,974,759
Native amount
49,000,000 USD
Stage
Series B
series b
Investors
6
Provenance & confidence
High confidenceAmount
49,000,000 USD
ECB-at-date → €45M · rate 1.0895 on 2023-01-26
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
6 namedAndera PartnersBritish Patient CapitalCanaan PartnersEarlybird Venture CapitalOxford Science EnterprisesPfizer Ventures
Date
Jan 2023
Round type
series b
Amount (EUR)
€45M
Other rounds
same companyRelated news
- Grey Wolf Therapeutics Closes $49M Series B Financingfinsmes.com · 2023-01